Novo Nordisk shares plunge 19% after disappointing trial results; Lilly jumps in premarket

Health

Novo Nordisk Shares Plunge 19% After Disappointing Trial Results; Lilly Jumps In Premarket

By CNBC

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 24% at one point on Friday after reporting results in a late-stage trial for its experimental CagriSema we ...Read more